JPMorgan upgrades Nike to overweight, citing a multiyear recovery path
CNBC: Investing
JULY 28, 2025
One of the parts is global inventory and sales growth finally "on track" to alignment by the end of the second quarter in 2026. Skip Navigation Markets Pre-Markets U.S. " The analyst believes Nike's multiyear recovery path is based on several key parts. our FY28 10.0% margin estimate)," he added.
Let's personalize your content